Fraidoon Kavoosi
Overview
Explore the profile of Fraidoon Kavoosi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanaei M, Kavoosi F
Asian Pac J Cancer Prev
. 2023 Jun;
24(6):1841-1854.
PMID: 37378911
Materials And Methods: The neuroblastoma and glioblastoma cells were cultured and treated with 5 AZA CdR. To determine cell viability, cell apoptosis, and the relative gene expression level, MTT assay,...
2.
Sanaei M, Kavoosi F
Int J Prev Med
. 2023 Jun;
14:63.
PMID: 37351028
Background: The alteration of DNA cytosine methylation is one of the most common epigenetic changes that can play a significant role in human cancers. The enzymes involved in DNA methylation...
3.
Sanaei M, Kavoosi F, Safari M
Adv Biomed Res
. 2023 Apr;
12:24.
PMID: 37057236
Background: Epigenetic mechanisms play an important role in the regulation of gene expression and genetic information. DNA methyltransferases are a family of enzymes that methylate DNA at the promoter region...
4.
Sanaei M, Kavoosi F, Poursadgh Soufiani I
Galen Med J
. 2023 Jan;
11:e2248.
PMID: 36698691
Histone deacetylase inhibitors (HDACIs) are novel anticancer agents that induce cell death and cycle arrest. Several studies reported that HDACIs induce apoptosis via two well-defined intrinsic/mitochondrial and death receptor pathways....
5.
Sanaei M, Kavoosi F
Res Pharm Sci
. 2022 Aug;
17(4):392-409.
PMID: 36034083
Background And Purpose: Epigenetics has been defined as the study of mitotically heritable alterations in gene expression that are not caused by changes in DNA sequence. Epigenetic-mediated silencing of a...
6.
Sanaei M, Kavoosi F, Safarzadeh M
Gastroenterol Hepatol Bed Bench
. 2022 May;
15(1):39-44.
PMID: 35611249
Aim: The current study aimed to investigate the effect of valproic acid (VPA) on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma...
7.
Sanaei M, Kavoosi F
Asian Pac J Cancer Prev
. 2022 Mar;
23(3):795-802.
PMID: 35345349
Background: In higher eukaryotes, cell-cycle transitions are regulated by different cyclin-dependent kinases (Cdks) and Cdk inhibitors (CKIs). CKIs include two groups, the Ink4 (p16INK4a, p15INK4b, p18INK4c, and p19INK4d) and the...
8.
Sanaei M, Kavoosi F
Iran J Pharm Res
. 2021 Dec;
20(3):324-336.
PMID: 34903992
Epigenetics is the study of heritable modifications in gene expression and reversible forms of gene regulation. Recent works have indicated that epigenetics plays a significant role in many types of...
9.
Sanaei M, Kavoosi F
Iran J Pharm Res
. 2021 Dec;
20(3):310-323.
PMID: 34903991
Aberrant histone modifications or promoter region hypermethylation of tumor suppressor genes (TSGs) have been recognized as the important epigenetic molecular mechanism in cancer induction. The potential anticancer activities of histone...
10.
Sanaei M, Kavoosi F
Gastroenterol Hepatol Bed Bench
. 2021 Oct;
14(4):323-333.
PMID: 34659660
Aim: The current study investigated the effect of trichostatin A (TSA) on mitochondrial/intrinsic [pro- (Bax, Bak, and Bim) and anti- (Bcl-2, Bcl-xL, and Mcl-1) apoptotic genes] and cytoplasmic/extrinsic (DR4, DR5,...